Skip to main content

Fennec Pharmaceuticals Inc(FENC-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Fennec Pharmaceuticals Inc

PO BOX 13628 68 TW ALEXANDER DRIVE
DURHAM NC 27709 USA
P: 919-636-4530
http://www.fennecpharma.com

Profile

Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly known as Adherex Technologies Inc., is based in United States.

Key Executives

NameTitle
Robert AndradeCFO/Chief Accounting Officer
Rostislav RaykovCEO/Director
Adrian J. HaighCOO

More from The Globe